CTKB Cytek Biosciences, Inc. - Common Stock
NASDAQ · Life Sciences Tools & Services · Wyświetl na SEC EDGAR ↗ 10-K/10-Q Sie 5, 2026
$5,59
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$3,3152tyg. minimum
$6,2152tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$727M
P/E
559.0
EPS
$-0.09
Przychody
$201M
Twoje odznaki
Zakres 52 tyg.
$3–$6
Ocena Analityków
BUY
Cena Docelowa
$6
P/E
559.0
ROE
-18.5%
Marża Zysku Netto
-39.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
CTKB Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$5.59
Kapitalizacja Rynkowa (MRQ)
$727M
P/E
559.0
EPS
$-0.09
Przychody
$201M
ROE
-18.5%
Zakres 52 tyg.
$3–$6
CTKB Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$201M2020-12-31 → 2025-12-31
EPS$-0.092020-12-31 → 2023-12-31
Wolny przepływ pieniężny$-9M2021-12-31 → 2025-12-31
Marża netto-39.0%2021-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | CTKB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E | 559.0średnia z 5 lat ≈390.8 | ≈390.8 | 72.4 | Zawyżona wycena | |
| P/S (TTM) | 3.5średnia z 5 lat ≈204.6 | ≈204.6 | 4.6 | Niedowartościowany | |
| P/B (MRQ) | 2.3średnia z 5 lat ≈3.1 | ≈3.1 | 1.8 | Wartość godziwa | |
| Cena / FCF (TTM) | -60.1średnia z 5 lat ≈1998.1 | ≈1998.1 | · | · | |
| Cena / Przepływy pieniężne (TTM) | -120.3średnia z 5 lat ≈95.7 | ≈95.7 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 2.4średnia z 5 lat ≈3.4 | ≈3.4 | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | CTKB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża brutto (TTM) | 53.2%średnia z 5 lat ≈57.5% | ≈57.5% | 45.8% | Najwyższa półka | |
| Marża Operacyjna (TTM) | -21.6%średnia z 5 lat ≈-7.7% | ≈-7.7% | -23.7% | Zgodnie z | |
| Marża EBITDA (TTM) | -17.9%średnia z 5 lat ≈-5.1% | ≈-5.1% | -23.7% | Zgodnie z | |
| Pretax Margin (Marża przed opodatkowaniem) | -14.8%średnia z 5 lat ≈-4.1% | ≈-4.1% | -20.8% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | -39.0%średnia z 5 lat ≈-7.7% | ≈-7.7% | -25.6% | Zgodnie z | |
| ROA | -13.9%średnia z 5 lat ≈-3.2% | ≈-3.2% | -13.9% | Zgodnie z | |
| ROE | -18.5%średnia z 5 lat ≈-4.3% | ≈-4.3% | -18.5% | Zgodnie z | |
| ROIC | -26.4%średnia z 5 lat ≈-7.4% | ≈-7.4% | -24.8% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | CTKB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 4.5średnia z 5 lat ≈8.0 | ≈8.0 | 4.5 | Zgodnie z | |
| Quick Ratio (Wskaźnik Szybkości) | 2.0średnia z 5 lat ≈5.4 | ≈5.4 | 1.7 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | CTKB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 0.52%średnia z 5 lat ≈1530.1% | ≈1530.1% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 7.1%średnia z 5 lat ≈302.1% | ≈302.1% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 209.5% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | CTKB | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.4średnia z 5 lat ≈0.4 | ≈0.4 | 0.3 | Najwyższa półka | |
| Inventory Turnover (Rotacja zapasów) | 2.1średnia z 5 lat ≈1.7 | ≈1.7 | 3.7 | Słaby | |
| Receivables Turnover (Rotacja należności) | 3.3średnia z 5 lat ≈4.0 | ≈4.0 | 5.7 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$295.4K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
-27.9%
Następny raport
Lis 11, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 12, 2026 | $-0.08 | $-0.09 | 7.7% |
| 31 marca 2026 | Maj 13, 2026 | $-0.15 | $-0.10 | -52.1% |
| 31 grudnia 2025 | $-0.04 | $-0.02 | -96.1% | |
| 30 września 2025 | $-0.04 | $-0.05 | 25.4% | |
| 30 czerwca 2025 | $-0.04 | $-0.07 | 44.0% | |
| 31 marca 2025 | $-0.09 | $-0.05 | -96.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $201M | $200M | $193M | $164M | $2M | $710.0K | |
| Cost of Revenue | $97M | $89M | $84M | $63M | $49M | $41M | |
| Gross Profit | $104M | $111M | $109M | $101M | $79M | $52M | |
| R&D Expense | $36M | $39M | $44M | $35M | $24M | $14M | |
| SG&A Expense | $59M | $43M | $44M | $35M | $21M | $9M | |
| Operating Expenses | $145M | $132M | $137M | $103M | $70M | $38M | |
| Operating Income | $-40M | $-21M | $-28M | $-2M | $9M | $14M | |
| Interest Expense | · | · | $2M | $3M | $2M | $333.0K | |
| Interest Income | $2M | $5M | $6M | $5M | $49.0K | $110.0K | |
| Other Non-op | $9M | $4M | $8M | $1M | $-2M | $994.0K | |
| Pretax Income | $-30M | $-6M | $-16M | $1M | $6M | $14M | |
| Income Tax | $37M | $320.0K | $-4M | $-1M | $3M | $-5M | |
| Net Income | $-67M | $-6M | $-12M | $2M | $3M | $19M | |
| EPS (Basic) | · | · | $-0.09 | $0.02 | $0.00 | $0.11 | |
| EPS (Diluted) | · | · | $-0.09 | $0.02 | $0.00 | $0.10 | |
| Shares (Basic) | 127,745,939 | 130,611,330 | 135,283,044 | 134,510,831 | 76,741,858 | 29,126,792 | |
| Shares (Diluted) | 127,745,939 | 130,611,330 | 135,283,044 | 138,562,111 | 81,542,729 | 32,599,847 | |
| EBITDA | $-33M | $-13M | $-22M | $688.0K | $10M | · |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $91M | $99M | $167M | $297M | $365M | $165M | |
| Receivables | $63M | $61M | $56M | $49M | $30M | $17M | |
| Inventory | $48M | $44M | $61M | $48M | $32M | $23M | |
| Prepaid Expense | $20M | $14M | $13M | $13M | $5M | $2M | |
| Other Current Assets | $3M | $2M | $2M | $4M | $708.0K | $445.0K | |
| Current Assets | $392M | $396M | $392M | $454M | $432M | $209M | |
| PP&E (Net) | $18M | $18M | $18M | $14M | $6M | $2M | |
| PP&E (Gross) | $30M | $27M | $24M | $17M | $8M | $3M | |
| Accum. Depreciation | $12M | $9M | $6M | $3M | $2M | $934.0K | |
| Goodwill | $17M | $17M | $16M | $10M | $10M | $476.0K | |
| Intangibles | $17M | $20M | $23M | $4M | $5M | $274.0K | |
| Other Non-current Assets | $7M | $5M | $3M | $3M | $2M | $1M | |
| Total Assets | $462M | $500M | $494M | $519M | $463M | $220M | |
| Accounts Payable | $23M | $21M | $20M | $21M | $15M | $9M | |
| Accrued Liabilities | $23M | $21M | $20M | $21M | $15M | $9M | |
| Current Liabilities | $78M | $68M | $56M | $49M | $33M | $27M | |
| Capital Leases | $14M | $8M | $9M | $12M | $0 | · | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $737.0K | |
| Total Liabilities | $120M | $104M | $101M | $94M | $58M | $42M | |
| Common Stock | $129.0K | $129.0K | $131.0K | $135.0K | $126.0K | $23.0K | |
| Paid-in Capital | $441M | $431M | $423M | $443M | $424M | $6M | |
| Retained Earnings | $-102M | $-35M | $-29M | $-17M | $-20M | $-23M | |
| AOCI | $2M | $16.0K | $-1M | $-697.0K | $897.0K | $65.0K | |
| Stockholders' Equity | $342M | $396M | $393M | $426M | $405M | $-16M | |
| Liabilities + Equity | $462M | $500M | $494M | $519M | $463M | $220M | |
| Shares Outstanding | 128,550,136 | 129,205,901 | 130,714,906 | 135,365,381 | 133,749,663 | 31,241,916 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $6M | $2M | $1M | $603.0K | |
| Stock-based Comp | $25M | $27M | $22M | $17M | $7M | $611.0K | |
| Deferred Tax | $34M | $-3M | $0 | $0 | $-2M | $-7M | |
| Amort. of Intangibles | $4M | $4M | $3M | $800.0K | $300.0K | $71.0K | |
| Other Non-cash | $-4M | $225.0K | $-638.0K | $-23M | $-4M | · | |
| Operating Cash Flow | $-5M | $25M | $5M | $-12M | $5M | $15M | |
| CapEx | $4M | $4M | $5M | $10M | $4M | $2M | |
| Investing Cash Flow | $10M | $-83M | $-94M | $-56M | $-21M | $-2M | |
| Stock Repurchased | $15M | $22M | $44M | $0 | $0 | · | |
| Net Stock Activity | $-15M | $-22M | $-44M | · | · | · | |
| Financing Cash Flow | $-13M | $-16M | $-42M | $6M | $214M | $123M | |
| Net Change in Cash | $-8M | $-69M | $-132M | $-65M | $198M | $136M | |
| Taxes Paid | $2M | $4M | $5M | $10M | $3M | $2M | |
| Free Cash Flow | $-9M | $22M | $633.0K | $-22M | $266.0K | · | |
| Levered FCF | · | · | $-968.5K | $-27M | $-621.5K | · |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% | · | |
| Operating Margin | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% | · | |
| Net Margin | -33.0% | -3.0% | -6.3% | 1.5% | 2.4% | · | |
| Pretax Margin | -14.8% | -2.8% | -8.1% | 0.77% | 4.6% | · | |
| EBITDA Margin | -16.3% | -6.6% | -11.3% | 0.42% | 8.1% | · | |
| ROA | -13.9% | -1.2% | -2.4% | 0.51% | 0.89% | · | |
| ROE | -18.5% | -1.5% | -3.0% | 0.59% | 0.75% | · | |
| ROIC | -26.4% | -5.5% | -5.5% | -0.84% | 1.1% | · |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 | · | |
| Quick Ratio | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 | · | |
| Interest Coverage | · | · | -13.4 | -0.7 | 5.3 | · |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.4 | 0.3 | 0.4 | · | |
| Inventory Turnover | 2.1 | 1.7 | 1.5 | 1.6 | 1.8 | · | |
| Receivables Turnover | 3.3 | 3.4 | 3.7 | 4.2 | 5.5 | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.66 | $3.06 | $3.01 | $3.14 | $3.03 | · | |
| Revenue / Share | $1.58 | $1.53 | $1.43 | $1.18 | $1.57 | · | |
| Cash Flow / Share | $-0.04 | $0.19 | $0.04 | $-0.09 | $0.06 | · | |
| Cash / Share | $0.71 | $0.76 | $1.28 | $2.19 | $2.73 | · | |
| EPS (TTM) | $0.01 | $0.01 | $-0.09 | $0.02 | $0.00 | · |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | 0.52% | 3.9% | 17.7% | 7421.1% | 207.2% | · | |
| Revenue CAGR 3Y | 7.1% | 351.3% | 547.8% | · | · | · | |
| Revenue CAGR 5Y | 209.5% | · | · | · | · | · | |
| Net Income YoY | · | · | · | -17.9% | -84.4% | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $201M | $200M | $193M | $164M | $2M | · | |
| Net Income TTM | $-67M | $-6M | $-12M | $2M | $3M | · | |
| Market Cap | $649M | $839M | $1.19B | $1.38B | $2.18B | · | |
| P/E | 505.0 | 649.0 | -101.3 | 510.5 | · | · | |
| P/S | 3.2 | 4.2 | 6.2 | 8.4 | 1000.8 | · | |
| P/B | 1.9 | 2.1 | 3.0 | 3.2 | 5.4 | · | |
| P / Tangible Book | 2.1 | 2.3 | 3.4 | 3.4 | 5.6 | · | |
| P / Cash Flow | -138.5 | 33.0 | 225.7 | -113.0 | 471.4 | · | |
| P / FCF | -74.0 | 38.4 | 1883.3 | -62.9 | 8206.0 | · | |
| Earnings Yield | 0.20% | 0.15% | -0.99% | 0.20% | 0.00% | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $48M | $44M | $62M | $52M | $46M | $41M | $57M | $52M | $47M | $45M | $58M | $48M | $50M | $37M | $48M | $40M | |
| Cost of Revenue | $20M | $23M | $29M | $25M | $22M | $21M | $24M | $22M | $21M | $22M | $25M | $21M | $22M | $16M | $19M | $14M | |
| Gross Profit | $28M | $21M | $33M | $28M | $24M | $20M | $34M | $29M | $25M | $23M | $33M | $27M | $28M | $21M | $29M | $27M | |
| R&D Expense | $10M | $10M | $9M | $9M | $9M | $10M | $10M | $10M | $10M | $10M | $11M | $11M | $12M | $10M | $10M | $9M | |
| SG&A Expense | $17M | $18M | $16M | $16M | $14M | $13M | $9M | $11M | $12M | $11M | $11M | $10M | $11M | $12M | $11M | $8M | |
| Operating Expenses | $40M | $40M | $38M | $37M | $34M | $35M | $31M | $33M | $34M | $34M | $33M | $34M | $37M | $33M | $29M | $26M | |
| Operating Income | $-11M | $-18M | $-6M | $-9M | $-11M | $-15M | $3M | $-4M | $-9M | $-11M | $-136.0K | $-6M | $-9M | $-12M | $84.0K | $1M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $441.0K | · | $595.0K | $409.0K | $673.0K | · | $649.0K | |
| Interest Income | $819.0K | $787.0K | $580.0K | $573.0K | $555.0K | $508.0K | $913.0K | $1M | $1M | $1M | $1M | $2M | $1M | $2M | $3M | $2M | |
| Other Non-op | $-781.0K | $565.0K | $257.0K | $1M | $4M | $3M | $490.0K | $3M | $59.0K | $823.0K | $3M | $1M | $2M | $2M | $2M | $-445.0K | |
| Pretax Income | · | · | $-4M | $-8M | $-7M | $-11M | $10M | $157.0K | $-7M | $-9M | $4M | $-4M | $-7M | $-9M | $4M | $2M | |
| Income Tax | $515.0K | $1M | $40M | $-2M | $-1M | $136.0K | $680.0K | $-784.0K | $3M | $-3M | $-1M | $2M | $-2M | $-2M | $396.0K | $224.0K | |
| Net Income | $-12M | $-19M | $-44M | $-5M | $-6M | $-11M | $10M | $941.0K | $-10M | $-6M | $6M | $-6M | $-4M | $-7M | $4M | $2M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-0.01 | |
| Shares (Basic) | 129,460,518 | 128,704,934 | · | 127,547,859 | 126,934,294 | 128,339,481 | · | 131,003,744 | 131,440,486 | 130,920,971 | · | 136,173,278 | 135,918,707 | 135,489,194 | · | 134,711,701 | |
| Shares (Diluted) | 129,460,518 | 128,704,934 | · | 127,547,859 | 126,934,294 | 128,339,481 | · | 132,785,552 | 131,440,486 | 130,920,971 | · | 136,173,278 | 135,918,707 | 135,489,194 | · | 138,709,335 | |
| EBITDA | $-11M | $-17M | · | $-9M | $-11M | $-13M | · | $-4M | $-9M | $-9M | · | $-6M | $-9M | $-11M | · | $1M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $74M | $66M | $91M | $93M | $75M | $95M | $99M | $162M | $178M | $169M | · | $164M | $132M | $129M | · | $342M | |
| Receivables | $50M | $52M | $63M | $57M | $56M | $55M | $61M | $53M | $45M | $50M | · | $55M | $50M | $43M | · | $40M | |
| Inventory | $52M | $50M | $48M | $52M | $49M | $45M | $44M | $47M | $50M | $55M | · | $67M | $66M | $70M | · | $49M | |
| Prepaid Expense | $14M | $15M | $20M | $18M | $15M | $15M | $14M | $13M | $12M | $13M | · | $12M | $11M | $11M | · | $13M | |
| Other Current Assets | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $1M | · | $2M | |
| Current Assets | $378M | $379M | $392M | $388M | $383M | $381M | $396M | $390M | $384M | $389M | · | $422M | $425M | $426M | · | $444M | |
| PP&E (Net) | $21M | $20M | $18M | $18M | $18M | $18M | $18M | $19M | $18M | $18M | · | $17M | $16M | $16M | · | $8M | |
| PP&E (Gross) | $35M | $34M | $30M | $30M | $29M | $27M | $27M | $27M | $25M | $24M | · | $22M | $20M | $19M | · | $10M | |
| Accum. Depreciation | $14M | $13M | $12M | $12M | $11M | $10M | $9M | $8M | $7M | $6M | · | $5M | $4M | $4M | · | $3M | |
| Goodwill | $17M | $17M | $17M | $17M | $17M | $17M | $17M | $16M | $16M | $16M | · | $16M | $19M | $19M | · | $10M | |
| Intangibles | $15M | $16M | $17M | $18M | $19M | $19M | $20M | $20M | $21M | $22M | · | $24M | $24M | $25M | · | $4M | |
| Other Non-current Assets | $6M | $6M | $7M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | · | $3M | $3M | $3M | · | $5M | |
| Total Assets | $447M | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | |
| Accounts Payable | $24M | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | |
| Accrued Liabilities | $24M | $20M | $23M | $20M | $22M | $19M | $21M | $21M | $15M | $18M | · | $21M | $20M | $20M | · | $17M | |
| Current Liabilities | $84M | $81M | $78M | $75M | $73M | $68M | $68M | $63M | $52M | $56M | · | $59M | $54M | $57M | · | $41M | |
| Capital Leases | $14M | $13M | $14M | $13M | $14M | $7M | $8M | $8M | $8M | $9M | · | $10M | $11M | $12M | · | $14M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $1M | |
| Total Liabilities | $125M | $121M | $120M | $116M | $116M | $103M | $104M | $106M | $95M | $99M | · | $104M | $101M | $101M | · | $83M | |
| Common Stock | $130.0K | $129.0K | $129.0K | $128.0K | $127.0K | $128.0K | $129.0K | $130.0K | $132.0K | $131.0K | · | $136.0K | $136.0K | $136.0K | · | $135.0K | |
| Paid-in Capital | $452M | $446M | $441M | $435M | $430M | $427M | $431M | $430M | $435M | $429M | · | $452M | $454M | $448M | · | $437M | |
| Retained Earnings | $-133M | $-121M | $-102M | $-58M | $-52M | $-47M | $-35M | $-45M | $-46M | $-35M | · | $-35M | $-28M | $-24M | · | $-21M | |
| AOCI | $3M | $2M | $2M | $821.0K | $-38.0K | $-609.0K | $16.0K | $101.0K | $-195.0K | $-2M | · | $-2M | $-2M | $-587.0K | · | $-530.0K | |
| Stockholders' Equity | $322M | $328M | $342M | $379M | $378M | $380M | $396M | $385M | $389M | $393M | · | $416M | $424M | $423M | $426M | $417M | |
| Liabilities + Equity | $447M | $449M | $462M | $495M | $493M | $483M | $500M | $491M | $484M | $492M | · | $519M | $525M | $525M | · | $499M | |
| Shares Outstanding | 129,982,753 | 129,142,587 | 128,550,136 | 127,864,830 | 127,185,113 | 127,599,142 | 129,205,901 | 129,766,011 | 131,505,201 | 131,254,181 | · | 135,545,663 | 136,344,908 | 135,644,055 | · | 134,849,139 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $761.0K | $72.0K | |
| Stock-based Comp | $5M | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $7M | $6M | $6M | $6M | $6M | $5M | $4M | $4M | |
| Deferred Tax | $0 | $-183.0K | $39M | $-3M | $-2M | $-336.0K | $-3M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Amort. of Intangibles | $900.0K | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $1M | $900.0K | $900.0K | $900.0K | $800.0K | $900.0K | $1M | $500.0K | $-353.0K | $200.0K | |
| Other Non-cash | · | $10M | · | · | · | $3M | · | · | · | $3M | · | · | · | $4M | · | · | |
| Operating Cash Flow | $1M | $-3M | $-771.0K | $-4M | $108.0K | $-125.0K | $2M | $13M | $6M | $4M | $10M | $-4M | $-3M | $3M | $6M | $-8M | |
| CapEx | $2M | $2M | $1M | $657.0K | $2M | $849.0K | $894.0K | $1M | $1M | $567.0K | $2M | $1M | $1M | $505.0K | $7M | $1M | |
| Investing Cash Flow | $7M | $-27M | $-2M | $19M | $-16M | $9M | $-63M | $-16M | $2M | $-6M | $29M | $43M | $3M | $-169M | $-51M | $-1M | |
| Stock Repurchased | $0 | $0 | $-34.0K | $-29.0K | $5M | $11M | $7M | $12M | $3M | $0 | $35M | · | · | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $-11M | · | $-12M | $-3M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-814.0K | $4M | $-1M | $2M | $-3M | $-12M | $-4M | $-12M | $-2M | $2M | $-34M | $-8M | $216.0K | $0 | $4M | $155.0K | |
| Net Change in Cash | $8M | $-25M | $-2M | $18M | $-20M | $-3M | $-64M | $-16M | $9M | $2M | $4M | $32M | $-850.0K | $-167M | $-42M | $-8M | |
| Taxes Paid | $610.0K | $-4M | $2M | $0 | $25.0K | $0 | $2M | $864.0K | $1M | $0 | $4M | $127.0K | $590.0K | $93.0K | $460.0K | $2M | |
| Free Cash Flow | · | $-5M | · | · | · | $-974.0K | · | · | · | $3M | · | · | · | $2M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $3M | · | · | · | $2M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.9% | 48.2% | · | 52.7% | 52.3% | 48.6% | · | 56.3% | 54.6% | 51.3% | · | 56.6% | 56.7% | 56.7% | · | 66.4% | |
| Operating Margin | -23.7% | -41.8% | · | -17.6% | -23.3% | -36.1% | · | -8.2% | -18.3% | -23.9% | · | -13.4% | -18.4% | -32.8% | · | 3.4% | |
| Net Margin | -25.3% | -42.8% | · | -10.5% | -12.2% | -27.5% | · | 1.8% | -22.4% | -13.8% | · | -13.5% | -8.8% | -18.4% | · | 4.0% | |
| Pretax Margin | · | · | · | -14.9% | -14.9% | -27.2% | · | 0.30% | -15.4% | -20.1% | · | -8.7% | -13.3% | -24.4% | · | 4.6% | |
| EBITDA Margin | -23.7% | -37.6% | · | -17.6% | -23.3% | -31.6% | · | -8.2% | -18.3% | -20.1% | · | -13.4% | -18.4% | -30.1% | · | 3.4% | |
| ROA | -2.6% | -4.0% | · | -1.1% | -1.1% | -2.3% | · | 0.19% | -2.1% | -1.2% | · | -1.3% | -0.86% | -1.4% | · | 0.34% | |
| ROE | -3.5% | -5.3% | · | -1.4% | -1.5% | -2.9% | · | 0.23% | -2.6% | -1.5% | · | -1.6% | -1.1% | -1.6% | · | 0.40% | |
| ROIC | · | · | · | -1.7% | -2.3% | -4.0% | · | -6.6% | -3.2% | -1.9% | · | -2.4% | -1.4% | -2.2% | · | 0.29% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.5 | 4.7 | · | 5.2 | 5.2 | 5.6 | · | 6.2 | 7.3 | 7.0 | · | 7.2 | 7.9 | 7.5 | · | 10.7 | |
| Quick Ratio | 1.5 | 1.5 | · | 2.0 | 1.8 | 2.2 | · | 3.4 | 4.2 | 3.9 | · | 3.7 | 3.4 | 3.1 | · | 9.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -24.3 | · | -10.8 | -22.3 | -18.1 | · | 2.1 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | |
| Receivables Turnover | 0.9 | 0.8 | · | 1.0 | 0.9 | 0.8 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.1 | 1.0 | · | 1.2 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.48 | $2.54 | · | $2.96 | $2.97 | $2.98 | · | $2.97 | $2.96 | $2.99 | · | $3.07 | $3.11 | $3.12 | · | $3.09 | |
| Revenue / Share | $0.37 | $0.34 | · | $0.41 | $0.36 | $0.32 | · | $0.39 | $0.35 | $0.34 | · | $0.35 | $0.37 | $0.27 | · | $0.29 | |
| Cash Flow / Share | · | $-0.02 | · | · | · | $-0.00 | · | · | · | $0.03 | · | · | · | $0.02 | · | · | |
| Cash / Share | $0.57 | $0.51 | · | $0.73 | $0.59 | $0.75 | · | $1.25 | $1.35 | $1.29 | · | $1.21 | $0.96 | $0.95 | · | $2.53 | |
| EPS (TTM) | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 | $0.01 | $0.01 | · | $0.01 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $207M | $204M | · | $197M | $196M | $197M | · | $201M | $198M | $201M | · | $183M | $176M | $166M | · | $29M | |
| Net Income TTM | $-81M | $-74M | · | $-13M | $-6M | $-11M | · | $-10M | $-18M | $-12M | · | $-14M | $-6M | $-2M | · | $-2M | |
| Market Cap | $576M | $564M | · | $444M | $432M | $512M | · | $719M | $734M | $881M | · | $748M | $1.16B | $1.25B | · | $1.98B | |
| P/E | 443.0 | 437.0 | · | 347.0 | 340.0 | 401.0 | · | 554.0 | 558.0 | 671.0 | · | 552.0 | 854.0 | 919.0 | · | 1472.0 | |
| P/S | 2.8 | 2.8 | · | 2.3 | 2.2 | 2.6 | · | 3.6 | 3.7 | 4.4 | · | 4.1 | 6.6 | 7.5 | · | 68.9 | |
| P/B | 1.8 | 1.7 | · | 1.2 | 1.1 | 1.3 | · | 1.9 | 1.9 | 2.2 | · | 1.8 | 2.7 | 2.9 | · | 4.8 | |
| P / Tangible Book | 2.0 | 1.9 | · | 1.3 | 1.3 | 1.5 | · | 2.1 | 2.1 | 2.5 | · | 2.0 | 3.1 | 3.3 | · | 4.9 | |
| P / Cash Flow | · | -206.3 | · | · | · | -4093.4 | · | · | · | 222.6 | · | · | · | 436.2 | · | · | |
| Earnings Yield | 0.23% | 0.23% | · | 0.29% | 0.29% | 0.25% | · | 0.18% | 0.18% | 0.15% | · | 0.18% | 0.12% | 0.11% | · | 0.07% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $201M | $200M | $193M | $164M | $2M |
| Marża Brutto % | 51.8% | 55.4% | 56.7% | 61.6% | 61.9% |
| Marża Operacyjna % | -20.0% | -10.2% | -14.4% | -1.1% | 7.2% |
| Zysk netto | $-67M | $-6M | $-12M | $2M | $3M |
| Rozwodniony EPS | · | · | $-0.09 | $0.02 | $0.00 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 5.0 | 5.9 | 7.0 | 9.3 | 13.0 |
| Wskaźnik Szybkości | 2.0 | 2.4 | 4.0 | 7.0 | 11.9 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-9M | $22M | $633.0K | $-22M | $266.0K |
Właściciele instytucjonalni (13F) 158 emitentów · $387.3M łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
158
Wartość posiadanych akcji
$387.3M
Nowe pozycje
30
Zamknięte pozycje
38
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 30 (+3 vs poprzedni kw.) | 38 (+27 vs poprzedni kw.) | 45 (-21 vs poprzedni kw.) | 63 (+14 vs poprzedni kw.) | -3.0M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $42 433 388 | 9 578 643 | 10,95% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $41 367 384 | 9 338 010 | 10,68% | Akcje |
| VANGUARD GROUP INC | $37 751 160 | 7 475 477 | 9,75% | Akcje |
| Boston Partners | $33 942 877 | 7 660 943 | 8,76% | Akcje |
| HHLR ADVISORS, LTD. | $29 490 643 | 6 657 030 | 7,61% | Akcje |
| Topline Capital Management, LLC | $27 835 684 | 6 283 450 | 7,19% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $21 882 415 | 4 939 597 | 5,65% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $13 557 155 | 3 059 573 | 3,50% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $11 589 081 | 2 616 257 | 2,99% | Akcje |
| STATE STREET CORP | $11 367 916 | 2 566 121 | 2,93% | Akcje |
| GOLDMAN SACHS GROUP INC | $9 602 092 | 2 167 515 | 2,48% | Akcje |
| ROYCE & ASSOCIATES LP | $9 221 395 | 2 081 579 | 2,38% | Akcje |
| Russell Investments Group, Ltd. | $6 695 120 | 1 511 315 | 1,73% | Akcje |
| BANK OF AMERICA CORP /DE/ | $5 826 921 | 1 315 332 | 1,50% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $5 057 253 | 1 141 592 | 1,31% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4 754 511 | 1 073 253 | 1,23% | Akcje |
| NORTHERN TRUST CORP | $4 444 592 | 1 003 294 | 1,15% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $4 314 080 | 973 833 | 1,11% | Akcje |
| JANE STREET GROUP, LLC | $4 014 298 | 906 162 | 1,04% | Akcje |
| TUDOR INVESTMENT CORP ET AL | $3 711 955 | 837 913 | 0,96% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $3 605 891 | 813 971 | 0,93% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $3 281 133 | 740 662 | 0,85% | Akcje |
| CITADEL ADVISORS LLC | $3 196 112 | 721 470 | 0,83% | Akcje |
| MORGAN STANLEY | $3 108 937 | 701 792 | 0,80% | Akcje |
| Qube Research & Technologies Ltd | $3 055 907 | 689 821 | 0,79% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $3 019 953 | 681 705 | 0,78% | Akcje |
| D. E. Shaw & Co., Inc. | $2 964 476 | 669 182 | 0,77% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $2 929 559 | 661 300 | 0,76% | Akcje |
| FMR LLC | $2 234 426 | 504 385 | 0,58% | Akcje |
| MARSHALL WACE, LLP | $1 956 749 | 441 704 | 0,51% | Akcje |
| Point72 Asset Management, L.P. | $1 871 059 | 422 361 | 0,48% | Akcje |
| Jain Global LLC | $1 822 790 | 411 465 | 0,47% | Akcje |
| Bank of New York Mellon Corp | $1 645 422 | 371 427 | 0,42% | Akcje |
| AMERICAN CENTURY COMPANIES INC | $1 294 016 | 292 103 | 0,33% | Akcje |
| Nuveen, LLC | $1 282 109 | 289 415 | 0,33% | Akcje |
| Connor, Clark & Lunn Investment Management Ltd. | $1 182 535 | 266 938 | 0,31% | Akcje |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 070 204 | 241 581 | 0,28% | Akcje |
| BNP PARIBAS FINANCIAL MARKETS | $952 494 | 215 010 | 0,25% | Akcje |
| Invesco Ltd. | $822 522 | 185 671 | 0,21% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $745 206 | 168 218 | 0,19% | Akcje |
| Numerai GP LLC | $706 430 | 159 465 | 0,18% | Akcje |
| FRANKLIN RESOURCES INC | $691 350 | 156 061 | 0,18% | Akcje |
| RHUMBLINE ADVISERS | $678 777 | 153 225 | 0,18% | Akcje |
| CenterBook Partners LP | $660 867 | 149 180 | 0,17% | Akcje |
| Jump Financial, LLC | $656 007 | 148 083 | 0,17% | Akcje |
| XTX Topco Ltd | $632 263 | 142 723 | 0,16% | Akcje |
| ALLIANCEBERNSTEIN L.P. | $616 380 | 141 048 | 0,16% | Akcje |
| JPMORGAN CHASE & CO | $615 690 | 141 864 | 0,16% | Akcje |
| Cubist Systematic Strategies, LLC | $542 566 | 156 359 | 0,14% | Akcje |
| DEUTSCHE BANK AG\ | $495 859 | 111 932 | 0,13% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×4 zgłoszenia | 19 września 2023 | · | Pierwotne zgłoszenie | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 19 insiderów · 10 dyrektorzy generalni · 11 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Wenbin Jiang | PRESIDENT AND CEO | 18 sierpnia 2026 M | 5 561 029 | 0 | 0 | $0 |
| William D. Mccombe | Chief Financial Officer | 18 sierpnia 2026 M | 134 693 | 0 | 0 | $0 |
| Patrick Jeanmonod | CHIEF FINANCIAL OFFICER | 11 marca 2024 M | 97 465 | 0 | 0 | $0 |
| Paul Christopher Williams | CHIEF OPERATING OFFICER | 19 sierpnia 2024 M | 16 473 | 0 | 0 | $0 |
| Ming Yan | CHIEF TECHNOLOGY OFFICER | 18 sierpnia 2026 M | 4 821 870 | 0 | 0 | $0 |
| Ilan Feuchtwang | Chief Legal Officer, Secretary | 10 sierpnia 2026 A | · | 0 | 0 | $0 |
| Philippe Busque | SVP, GLOBAL SALES AND SERVICES | 18 maja 2026 M | 43 466 | 0 | 0 | $0 |
| Valerie Barnett | CHIEF LEGAL OFFICER | 18 maja 2026 M | 150 012 | 0 | 0 | $0 |
| Allen Poirson | SVP BUS. AND CORP. DEV. | 18 listopada 2024 M | 59 981 | 0 | 0 | $0 |
| Jonathan Todd Garland | Chief Commercial Officer | 18 sierpnia 2023 M | 8 763 | 0 | 0 | $0 |
| Michael Holder | Dyrektor | 18 sierpnia 2026 M | 62 875 | 0 | 0 | $0 |
| Richard Chin | Dyrektor | 18 sierpnia 2026 M | 28 499 | 0 | 0 | $0 |
| Glenn P Muir | Dyrektor | 18 sierpnia 2026 M | 3 086 | 0 | 0 | $0 |
| Vera Imper | Dyrektor | 10 czerwca 2026 M | 59 679 | 0 | 0 | $0 |
| Jack Ball | Dyrektor | 10 czerwca 2026 M | 86 678 | 0 | 0 | $0 |
| Deborah J Neff | Dyrektor | 10 czerwca 2026 M | 59 679 | 0 | 0 | $0 |
| Don M Hardison | Dyrektor | 5 czerwca 2025 M | 15 706 | 0 | 0 | $0 |
| Gisele Dion | Dyrektor | 14 czerwca 2023 A | 5 000 | 0 | 0 | $0 |
| Feng Deng | Dyrektor | 22 lipca 2021 C | 443 800 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 21 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IBB · iShares Trust | 0,04% | 911 338 SH | 11 września 2026 | Dziennie |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 106 025 SH | 19 sierpnia 2026 | Dziennie |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 120 715 SH | 23 października 2026 | Dziennie |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 700 141 SH | 19 sierpnia 2026 | Dziennie |
| IWM · iShares Trust | 0,02% | 3 106 810 SH | 11 września 2026 | Dziennie |
| RSSL · Global X Funds | 0,02% | 58 111 NS | 31 lipca 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 1 299 836 SH | 19 sierpnia 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,01% | 325 613 SH | 19 sierpnia 2026 | Dziennie |
| DFAS · Dimensional ETF Trust | 0,01% | 292 301 NS | 31 lipca 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 372 840 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 3 616 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 10 300 NS | 31 lipca 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 12 189 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 26 782 NS | 31 lipca 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,00% | 18 244 NS | 31 lipca 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 119 354 SH | 11 września 2026 | Dziennie |
| IWV · iShares Trust | 0,00% | 28 666 SH | 11 września 2026 | Dziennie |
| DFUS · Dimensional ETF Trust | 0,00% | 30 693 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3 525 848 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9 813 SH | 19 sierpnia 2026 | Dziennie |
| IWN · iShares Trust | · | 1 134 041 SH | 11 września 2026 | Dziennie |
CTKB Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 10 analityków
KUP
Średni cel
$5.00
-10,6%
3 30,0%
Mocne kupno
4 40,0%
Kup
3 30,0%
Trzymaj
0 0,0%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
4 analityków · 2026-10-21Średnia cel $5.56 -0,5%
Teraz
Aktualna cena $5.59
Niski$4.75
Średnia$5.56
Wysoki$7.50
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| CTKB | $649M | 505.0 | 0.52% | -33.0% | -18.5% | 51.8% |
| MRVI | · | -3.6 | -28.3% | -70.4% | -48.6% | 18.3% |
| PSNL | $816M | -8.7 | -17.7% | -116.7% | -36.0% | · |
| AZTA | $1.32B | -23.5 | 3.5% | -9.4% | -3.3% | 45.5% |
| CYRX | $479M | 6.9 | 12.4% | 44.4% | 15.3% | 47.1% |
| MLAB | $489M | 73.1 | 3.4% | 2.7% | 3.7% | 63.5% |
| OABI | · | · | · | · | · | · |
| DNA | $484M | -1.5 | -25.1% | -183.8% | -55.8% | · |
| PACB | $565M | -1.0 | 3.9% | -341.5% | -1634.9% | 28.6% |
| NAUT | $247M | -4.1 | · | · | -34.9% | · |
| TKNO | $204M | -11.9 | 7.3% | -42.6% | -23.8% | 33.2% |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 5, 2026